Fact CheckerSign in

NCT06464874Completed

Endoscopic Therapy for Laterally Spreading Tumors (LSTs)

Hybrid Versus Conventional Endoscopic Submucosal Dissection for Laterally Spreading Tumors (LSTs): A Retrospective Multicenter Study

Source: ClinicalTrials.gov · Last updated 18 Jun 2024

Brief summary (registry, in English)

This study will retrospectively include LST patients who were admitted to 6 medical centers (The Second Affiliated Hospital, College of Medicine, Zhejiang University; The Affiliated Jinhua Hospital, Zhejiang University School of Medicine; First Affiliated Hospital of Huzhou University; The Second Hospital of Jiaxing; Jinhua People's Hospital; Lanxi People's Hospital) from 2020.05.01 to 2023.04.30 with the purpose of comparing the efficacy and safety of hybrid ESD and ESD in the treatment of colorectal LST. The complete resection rate, operation time, operation cost, intraoperative and postoperative complications of hybrid ESD and ESD LST will be compared. To provide strong evidence for the selection of endoscopic treatment strategies for LST.

Status (registry)
Completed
Study type
Observational
Enrollment
890 (actual)
First submitted
13 Jun 2024
Start date
1 May 2020
Primary completion date
30 Apr 2023
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
NCT number
NCT06464874

What you commit to

  • Study type: Observational
  • Participants enrolled: 890
  • From 1 May 2020 to the primary completion date, 30 Apr 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Resection of residual lesions after endoscopic treatment;
  • Taking nonsteroidal anti-inflammatory drugs or anticoagulants;

Other illness

  • The lesions are in patients with inflammatory bowel disease;
  • A history of alcoholism;
  • Severe organ failure;

Other

  • Pedicle lesions;
  • Advanced endoscopic imaging showed submucosal infiltrating lesions.
  • Familial polyposis;
  • Electrolyte abnormalities;
  • Coagulation dysfunction;
  • Pregnant or lactating patients;
  • Medical records are incomplete

Who the study is looking for

  • Age ≥18 years old;
  • LST lesion diameter \>1cm;
  • Medical record data integrity

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.